Cytomegalovirus Infections, Heart Transplantation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cytomegalovirus Infections, Heart Transplantation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 2

NCT06066957

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Open label study to determine tolerability and efficacy of letermovir for CMV prophylaxis in heart and lung transplant recipients. The study hypotheses are: 1.…

United States80 participantsStarted 2024-04-04

Treatment: Letermovir 480 MG [Prevymis]

RecruitingNot Applicable

NCT06341543

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

Context Cytomegalovirus (CMV) infection is a frequent and potentially severe event in solid organ transplant (SOT) recipients. Most of available treatment dis…

France288 participantsStarted 2024-09-24

Treatment: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes)., Communication of the result of the QF-CMV to the clinician in charge

All recent trials (11 shown)

CompletedNot Applicable

NCT03924219

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

CMV infection and disease remain a significant clinical challenge for pediatric solid organ transplant (SOT) recipients. Current prevention strategies are limit…

United States161 participantsStarted 2019-06-03

Treatment: CMV T cell Immunity Assay

CompletedPhase 4

NCT04904614

Letermovir Use in Heart Transplant Recipients

This is an open label trial in which letermovir will be given as prophylaxis for the prevention of cytomegalovirus (CMV) infection and disease to all heart tran…

United States32 participantsStarted 2022-01-05

Treatment: Letermovir

Cytomegalovirus Infections, Heart Transplantation

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

All recent trials (11 shown)

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Letermovir Use in Heart Transplant Recipients

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

All recent trials (11 shown)

CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

Letermovir Use in Heart Transplant Recipients

Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant P…

A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Tha…

Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients

Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy

Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients